No tags found.
No abstract available.
Citation
O'Donnell RT, Pearson D, McKnight HC, Ma YP, Tuscano JM. Treatment of non-Hodgkin's lymphoma xenografts with the HB22.7 anti-CD22 monoclonal antibody and phosphatase inhibitors improves efficacy. Cancer immunology, immunotherapy : CII. 2009 Oct;58(10):1715-22
PMID: 0
View Full Text
